Even though all CCA patients had positive NF-κB signals, no relationships between NF-κB expressions and clinico-pathological findings eg. age, sex, tumor staging, tumor size, tumor type and metastasis status, and the cumulative survival of the patients were noted (data not shown). The gene discussed is NFKB1; the disease is cholangiocarcinoma.